Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent ...
Generated fourth quarter and full-year 2024 net product sales of XDEMVY® of $66.4 million and $180.1 million, respectively, during the first full ...
ophthalmologytimes6 天
Alcon announces US launch of Voyager direct selective laser trabeculoplasty device
The first-line laser treatment for glaucoma and ocular hypertension will be unveiled at the 2025 American Glaucoma Society ...